Skip to content

SCHEDULE 13D/AAccepted Sep 18, 7:08 PM ET

LAVA Therapeutics NV SCHEDULE 13D/A

Versant Venture Capital VI, L.P.

Accepted (ET)

7:08 PM

Sep 18, 2025

Filed

Sep 18, 2025

Documents

1

Size

19.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.